Survey

NPACE Webinar Post

I am a(n)…

[ Required ]

Select...

How many years have you been in practice?

[ Required ]

Select...

What is your practice setting?

[ Required ]

Select...

Number of patients seen per month with T2DM

[ Required ]

Number of patients seen per month with CKD or DKD?

[ Required ]

Select...

Please rate the following:

Degree to which your educational expectations were met

[ Required ]

Select...

Relevance to your practice

[ Required ]

Select...

Effective faculty presenter

[ Required ]

Select...

Overall Presentation

[ Required ]

Select...

Please rate the degree to which the Learning Objectives were met.

Identify the risks of kidney disease and their consequences in patients with T2DM.

[ Required ]

Select...

Appropriately screen for the presence of CKD in patients with T2DM.

[ Required ]

Select...

Initiate evidence-based therapy to slow the progression of kidney disease in patients with T2DM and CKD.

[ Required ]

Select...

Become familiar with the mineralocorticoid receptor antagonists and their role in the treatment of patients with DKD.

[ Required ]

Select...

Agree or Disagree?

The presentation was fair and balanced, free of commercial bias.

[ Required ]

Select...

I feel more competent as a result of the presentation.

[ Required ]

Select...

The presentation was scientifically rigorous.

[ Required ]

Select...

The content contributed valuable information that will assist in improving patient outcomes

[ Required ]

Select...

Will you change your practice behaviors as a result of the presentation?

[ Required ]

Select...

What will you change?

[ Required ]

If Other

Because you are likely to make changes to your practice behaviors, you are eligible to qualify for T2P (Translation to Practice) Credit, an additional 2.0 Credits. Please provide your email address below and we will send you a link to a followup survey in six weeks. If you have made changes to your practice behaviors, you will receive those additional two credits.

[ Invalid e-mail address ]

What barriers to change do you foresee?

[ Required ]

If Other

What was your level of knowledge on this subject?

Before the presentation

[ Required ]

Select...

After the presentation

[ Required ]

Select...

When compared to people with T2DM without kidney disease, the presence of albuminuria and decreased eGFR increases the 10-year mortality incidence by how much?

[ Required ]

Which of the following is true of the recommendation for use of finerenone in people with T2D and CKD by the ADA/KDIGO?

[ Required ]

How confident do you feel in your answer to the previous question?

[ Required ]

Select...

What do you need to learn more about on this topic?